642
Participants
Start Date
November 14, 2023
Primary Completion Date
August 5, 2025
Study Completion Date
November 28, 2026
AK104
AK104 IV, q3w
Tislelizumab
Tislelizumab IV, q3w
carboplatin
carboplatin IV, q3w
Pemetrexed
Pemetrexed IV, q3w (for Nonsquamous NSCLC)
Paclitaxel
Paclitaxel IV, q3w (for squamous NSCLC)
The First Affiliated Hospital of Xinxiang Medical College, Xinxiang
Cancer hospital, Chinese academy of medical sciences and Peking union medical college, Beijing
The Fifth Medical Center of the Chinese People's Liberation Army General Hospital, Beijing
Beijing Cancer Hospital, Beijing
Beijing Chest hospital, Beijing
The First Hospital of China medical University, Shenyang
Liaoning cancer hospital, Shenyang
The first hospital of Jilin Universit, Changchun
Tonghua Central Hospital, Tonghua
Harbin medical university cancer hospital, Harbin
Jiamusi Tuberculosis Prevention and Control Hospital (Jiamusi Cancer Hospital), Jiamusi
The first hospital of Qiqihar, Qiqihar
Zhongshan Hospital, Fudan university, Shanghai
The First Affiliated Hospital of Soochow University, Suzhou
The affiliated hospital of xuzhou medical university, Xuzhou
Anhui provincial hospital, Hefei
Anhui provincial cancer hospital, Hefei
The first affiliated hospital of bengbu medical college, Bengbu
The first affiliated hospital of wannan medical college, Wuhu
Shandong Cancer Hospital, Jinan
Binzhou medical university hospital, Binzhou
Weifang NO.2 people's Hospital, Weifang
The Affiliated Hospital of Qingdao University, Qingdao
Tianjin Medical University Cancer Institute & Hospital, Tianjin
Tianjin Chest Hospital, Tianjin
The First Affiliated Hospital, Zhejiang University School of Medicine (FAHZU), Hangzhou
Zhejiang Cancer Hospital, Hangzhou
First Affiliated Hospital of Nanchang University, Nanchang
First Affiliated Hospital of Gannan medical college, Ganzhou
Fujian cancer hospital, Fuzhou
Zhangzhou municipal hospital of fujian province, Zhangzhou
Chongqing University Cancer Hospital, Chongqing
Xiangya Hospital of Central South University, Changsha
The Second Xiangya Hospital, Central South University, Changsha
Hunan Cancer Hospital, Changsha
Renmin Hospital of Wuhan University, Wuhan
Hubei Cancer Hospital, Wuhan
Henan Cancer Hospital, Zhengzhou
The First Affiliated Hospital of Henan University of Science and Technology, Luoyang
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
Nanyang central hospital, Nanyang
The First Affiliated Hospital of Sun Yat-sen University, Guangzhou
Affiliated cancer hospital and institute of guangzhou medical university, Guangzhou
Nanfang hospital, Guangzhou
Cancer hospital Chinses academy of medical sciences, shenzhen center, Shenzhen
Hainan cancer hospital, Haikou
Sichuan Cancer Hospital, Chengdu
Mianyang central hospital, Mianyang
The Second People's Hospital of Yibin City, Yibin
Yunnan Cancer Hospital /the Third Affiliated Hospital of Kunming Medical University, Kunming
The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an
Gansu provincial cancer hospital, Lanzhou
General hospital of ningxia medical university, Yinchuan
Qinghai university affiliated hospital, Xining
Xinjiang Medical University Cancer Hospital, Ürümqi
Affiliated hospital of Hebei university, Baoding
The second people's hospital of Hengshui, Hengshui
The Second Hospital of HeBei Medical University, Shijiazhuang
The Fourth Hospital of Hebei Medical University, Shijiazhuang
Tangshang people's hospital, Tangshan
Changzhi people's hospital, Changzhi
Shanxi Cancer hospital, Taiyuan
Lead Sponsor
Akeso
INDUSTRY